Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a phone app help stroke patients recover? new trial aims to find out

NCT ID NCT07511868

Disease control Sponsor: VASCage GmbH Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests a smartphone app called StrokeApp designed to support people after a stroke or mini-stroke. The app provides educational content, medication reminders, and tools to track health. Researchers will compare quality of life and other health measures between 500 patients who use the app plus standard care versus those who receive standard care alone.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
StrokeApp (smartphone/tablet-based medical application)
What this could lead to
If it works, this could provide an effective, low-cost digital tool to help stroke survivors improve their quality of life and better manage their health after leaving the hospital.
What could go wrong
This is a relatively early-stage trial testing a behavioral intervention, not a drug. The app's benefits may be small or not last long, and results depend on patients actually using it consistently.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 500 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Apr 2026

An estimate. Start dates often move.

Expected to finish

Dec 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Male or female patient (biological sex) ≥18 years at the time of consent 2. Hospitalization for acute ischemic stroke, acute haemorrhagic stroke or TIA 3. Necessary Technical Equipment (smartphone or tablet computer) and skills 4. Able to provide informed consent Exclusion Criteria: 1. Cerebral infarction due to cerebral venous thrombosis (CVT) 2. Severe Psychiatric Conditions 3. Severe pre-existing cognitive impairment 4. Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH) or other patients where salt restriction is harmful. 5. Inability to operate the device independently (assistance from a caregiver is acceptable). E.g.: * Severe apraxia, * Severe Motor Disabilities, * Severe Visual Impairment * Severe Communication Barriers (e.g. Severe Aphasia, Severe Dysarthria) 6. Inability to speak and read German to a level which allows fully comprehending the meaning of everything that is said and written. 7. Women of childbearing potential not willing to adopt effective contraceptive measures during the clinical investigation 8. Patients who are considered to be part of the vulnerable population: * Persons unable to give consent * Minors * Persons performing military service * persons detained by court or official order or accommodated in accordance with the Accommodation Act, Federal Law Gazette No. 155/1990 * Pregnant or breastfeeding women

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Haemorrhagic stroke are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Alzheimer disease hemorrhagic stroke ischemic stroke transient ischemic attack

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Haemorrhagic stroke Ischaemic stroke Transient ischemic attack (TIA)

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    7 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Johannes Kepler University Linz, University Hospital for Neurology

    Linz, Upper Austria, 4021, Austria

  • Medical University of Graz, Clinical Department of General Neurology

    Graz, Styria, 8010, Austria

  • Medical University of Innsbruck, Department of Neurology

    Innsbruck, Tyrol, 6020, Austria

  • Pyhrn-Eisenwurzen Klinikum, Department of Neurology

    Steyr, Upper Austria, 4400, Austria

  • Salzkammergut Klinikum Vöcklabruck, Department of Neurology

    Vöcklabruck, Upper Austria, 4840, Austria

  • St. John's Hospital, Vienna Department of Neurology

    Vienna, State of Vienna, 1020, Austria

  • University Hospital Tulln, Clinical Department of Neurology

    Tulln, Lower Austria, 3430, Austria

More trials for these conditions

Other studies related to the condition(s) this trial covers.